029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
DLV751a肝癌及肝组织组合芯片(所有组织均从2014年后收集),附病理分级、TNM和临床分期,57例/75点
点 数75例 数57
行 数8列 数10
点直径(mm)1.5厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:DLV751a
 
肝癌及肝组织组合微阵列芯片,包含肝细胞肝癌28例,胆管细胞癌5例,混合癌2例,癌旁或边缘肝组织35例(其中18例与肝癌匹配),肝组织5例,一块一点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Liv
-Liver
 
AT (*)
 
Malignant (I)
 
Malignant (II)
 
Malignant (III)
 
Malignant (IIIA)
 
NAT (*)
 
Normal (*)
TISSUE  ARRAYS DLV751a
1
2
3
4
5
6
7
8
9
10
A
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
B
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
C
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
D
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
E
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
F
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
G
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
H
LIV
LIV
LIV
LIV
LIV
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeisBackUp
A1157FLiverHepatocellular carcinoma2T3N0M0IIIMalignantN
A2251MLiverHepatocellular carcinoma2T2N0M0IIMalignantN
A3352MLiverHepatocellular carcinoma2T2N0M0IIMalignantN
A4460MLiverHepatocellular carcinoma2T2N0M0IIMalignantN
A5561MLiverHepatocellular carcinoma2T2N0M0IIMalignantN
A6678MLiverHepatocellular carcinoma2T2N0M0IIMalignantN
A7768MLiverHepatocellular carcinoma2T3N0M0IIIMalignantN
A8840MLiverHepatocellular carcinoma2T3N0M0IIIMalignantN
A9945FLiverHepatocellular carcinoma2T2N0M0IIMalignantN
A101048MLiverHepatocellular carcinoma2T2N0M0IIMalignantN
B11145MLiverHepatocellular carcinoma2T1N0M0IMalignantN
B21235MLiverHepatocellular carcinoma2T3N0M0IIIMalignantN
B31355MLiverHepatocellular carcinoma3T2N0M0IIMalignantN
B41458MLiverHepatocellular carcinoma3T3N0M0IIIMalignantN
B51553FLiverHepatocellular carcinoma3T3N0M0IIIMalignantN
B61663MLiverHepatocellular carcinoma3T2N0M0IIMalignantN
B71758MLiverHepatocellular carcinoma3T3N0M0IIIMalignantN
B81862MLiverHepatocellular carcinoma3T3aN0M0IIIAMalignantN
B91965MLiverHepatocellular carcinoma3T3N0M0IIIMalignantN
B102077MLiverHepatocellular carcinoma3T3aN0M0IIIAMalignantN
C12138MLiverHepatocellular carcinoma2T3N0M0IIIMalignantN
C22272FLiverHepatocellular carcinoma2T3N0M0IIIMalignantN
C32331MLiverHepatocellular carcinoma3T2N0M0IIMalignantN
C42460MLiverHepatocellular carcinoma3T3N0M0IIIMalignantN
C52552MLiverHepatocellular carcinoma3T3N0M0IIIMalignantN
C62648MLiverHepatocellular carcinoma3T3N0M0IIIMalignantN
C72752FLiverHepatocellular carcinoma3T3aN0M0IIIAMalignantN
C82847MLiverHepatocellular carcinoma3T2N0M0IIMalignantN
C92954MLiverHepatocholangiocarcinoma*T3N0M0IIIMalignantN
C103057MLiverHepatocholangiocarcinoma*T2N0M0IIMalignantN
D13154MLiverHepatocholangiocarcinoma*T2N0M0IIMalignantN
D23242MLiverHepatocholangiocarcinoma*T2N0M0IIMalignantN
D33348MLiverHepatocholangiocarcinoma*T3aN0M0IIIAMalignantN
D43447MLiverMixed liver carcinoma*T2N0M0IIMalignantN
D53558MLiverMixed liver carcinoma*T3N0M0IIMalignantN
D63657FLiverAdjacent cirrhosis tissue of No.1***NATN
D73747MLiverAdjacent normal liver tissue***NATN
D83860MLiverAdjacent normal liver tissue***NATN
D93954MLiverCancer adjacent liver tissue***ATN
D104040MLiverCancer adjacent liver tissue***ATN
E14156MLiverCancer adjacent liver tissue***ATN
E24253MLiverAdjacent normal liver tissue***NATN
E34342MLiverCancer adjacent liver tissue***ATN
E44454MLiverAdjacent normal liver tissue***NATN
E54549MLiverAdjacent normal liver tissue***NATN
E64645MLiverAdjacent normal liver tissue of No.11***NATN
E74735MLiverAdjacent normal liver tissue of No.12***NATN
E84855MLiverAdjacent normal liver tissue of No.13***NATN
E94958MLiverCancer adjacent liver tissue of No.14***ATN
E105053FLiverCancer adjacent liver tissue of No.15***ATN
F15163MLiverAdjacent normal liver tissue of No.16***NATN
F25258MLiverAdjacent normal liver tissue of No.17***NATN
F35362MLiverAdjacent normal liver tissue of No.18***NATN
F45465MLiverCancer adjacent liver tissue of No.19***ATN
F55577MLiverCancer adjacent liver tissue of No.20***ATN
F65654MLiverCancer adjacent liver tissue***ATN
F75759MLiverAdjacent normal liver tissue***NATN
F85859MLiverCancer adjacent liver tissue***ATN
F95948MLiverCancer adjacent liver tissue***ATN
F106050FLiverAdjacent normal liver tissue***NATN
G16148MLiverCancer adjacent liver tissue of No.26***ATN
G26252FLiverAdjacent normal liver tissue of No.27***NATN
G36347MLiverAdjacent normal liver tissue of No. 28***NATN
G46454MLiverAdjacent normal liver tissue of No.29***NATN
G56534MLiverAdjacent normal liver tissue***NATN
G66654MLiverAdjacent normal liver tissue of No.31***NATN
G76767FLiverCancer adjacent liver tissue***ATN
G86852FLiverAdjacent normal liver tissue***NATN
G96947MLiverCancer adjacent liver tissue of No.34***ATN
G107058MLiverAdjacent normal liver tissue of No.35***NATN
H17156FLiverLiver tissue***NormalN
H27227FLiverLiver tissue***NormalN
H37323MLiverLiver tissue***NormalN
H47445MLiverLiver tissue***NormalN
H57536FLiverLiver tissue***NormalN
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情